NetworkNewsBreaks – Adaptogenics Health Corp. (CSE: ADPT) in Focus as Trump Administration Advances Peptide Access Policy, AP Reports
This article has been disseminated on behalf of Adaptogenics Health Corp. and may include paid advertising. Adaptogenics (CSE: ADPT) is positioned in a peptide market drawing increased attention as the Trump administration advances plans to ease restrictions on certain peptide compounds. According to The Associated Press via NBC News, the Department of Health and Human Services has submitted an interim access policy to the White House for review that could allow specialty pharmacies to temporarily produce certain peptides, including BPC-157, which is promoted for muscle growth and injury recovery. The proposal follows a July recommendation by external Food and Drug…







